Investor Alert

Company Close Updates Archives | Email alerts

April 22, 2021, 4:31 p.m. EDT

Moderna Inc. stock outperforms market despite losses on the day

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA sank 0.83% to $168.10 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.94% to 13,818.41 and Dow Jones Industrial Average DJIA falling 0.94% to 33,815.90. Moderna Inc. closed $21.16 below its 52-week high ($189.26), which the company reached on February 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. ABBV fell 0.68% to $110.05, Amgen Inc. AMGN fell 1.44% to $255.05, and AstraZeneca PLC ADR AZN fell 0.75% to $52.71. Trading volume (15.9 M) eclipsed its 50-day average volume of 8.9 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.